| Drug Name |
Alpha-1-proteinase inhibitor (human) |
| Drug ID |
BADD_D00084 |
| Description |
Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation. |
| Indications and Usage |
For chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema. |
| Marketing Status |
Not Available |
| ATC Code |
B02AB02 |
| DrugBank ID |
DB00058
|
| KEGG ID |
D11965
|
| MeSH ID |
D000515
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D9EC0G
|
| NDC Product Code |
0944-2814; 13533-703; 13533-706; 0944-2815; 13533-700 |
| Synonyms |
alpha 1-Antitrypsin | alpha 1 Antitrypsin | alpha 1 Antiprotease | Antiprotease, alpha 1 | Serpin A1 | alpha 1-Protease Inhibitor | Inhibitor, alpha 1-Protease | alpha 1 Protease Inhibitor | alpha 1-Proteinase Inhibitor | Inhibitor, alpha 1-Proteinase | alpha 1 Proteinase Inhibitor | Trypsin Inhibitor, alpha 1-Antitrypsin | Trypsin Inhibitor, alpha 1 Antitrypsin | A1PI | alpha 1-Antiproteinase | 1-Antiproteinase, alpha | alpha 1 Antiproteinase | Prolastin | Zemaira |
